Trevena Inc (NAS:TRVN)
$ 6.7 -0.79 (-10.55%) Market Cap: 5.71 Mil Enterprise Value: 26.50 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 23/100

Trevena Inc at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) Transcript

Sep 21, 2021 / 12:15PM GMT
Release Date Price: $762.5 (-2.40%)
Jeff Jones
Oppenheimer & Co. Inc. - Analyst

Thank you, everyone, and welcome to day 2 of Oppenheimer's Fall Healthcare and Life Sciences Summit. This is Jeff Jones. I am Senior Analyst here at Oppenheimer in our healthcare equity research group. And today, I'd like to welcome Carrie Bourdow and Barry Shin, CEO and CFO of Trevena. Looking forward to getting an update from you guys on all that's been going on this fall. So with that, I will hand it over. Take us away, Carrie.

Carrie Bourdow
Trevena, Inc. - President, CEO

Great. Thank you, Jeff. Thank you for inviting us to the conference. We are excited to provide an update as well. So as Jeff mentioned, I am Carrie Bourdow. I am the President and CEO of Trevena.

I will be making forward-looking statements. I encourage you to review our regulatory filings. It's an important slide for us to present.

So Trevena is a CNS-focused company with an innovative pipeline. We have also a platform technology that is important for us to highlight. The technology came out of Duke University, and the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot